A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of metformin to standard
chemotherapy improves progression free survival in women with metastatic breast cancer.